TOT BIOPHARM International Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Jun Liu
Chief executive officer
CN¥4.9m
Total compensation
| CEO salary percentage | 58.7% |
| CEO tenure | 5.1yrs |
| CEO ownership | n/a |
| Management average tenure | 3.6yrs |
| Board average tenure | 5.1yrs |
Recent management updates
Recent updates
Is TOT BIOPHARM International (HKG:1875) Using Debt In A Risky Way?
Mar 18
There's No Escaping TOT BIOPHARM International Company Limited's (HKG:1875) Muted Revenues
Dec 28Does TOT BIOPHARM International (HKG:1875) Have A Healthy Balance Sheet?
Nov 23We Think TOT BIOPHARM International (HKG:1875) Has A Fair Chunk Of Debt
May 18Here's Why We're Watching TOT BIOPHARM International's (HKG:1875) Cash Burn Situation
Jul 27An Intrinsic Calculation For TOT BIOPHARM International Company Limited (HKG:1875) Suggests It's 41% Undervalued
Mar 26Here's Why We're Watching TOT BIOPHARM International's (HKG:1875) Cash Burn Situation
Feb 03CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -CN¥38m |
| Sep 30 2023 | n/a | n/a | -CN¥44m |
| Jun 30 2023 | n/a | n/a | -CN¥49m |
| Mar 31 2023 | n/a | n/a | -CN¥50m |
| Dec 31 2022 | CN¥5m | CN¥3m | -CN¥50m |
| Sep 30 2022 | n/a | n/a | -CN¥106m |
| Jun 30 2022 | n/a | n/a | -CN¥162m |
| Mar 31 2022 | n/a | n/a | -CN¥212m |
| Dec 31 2021 | CN¥3m | CN¥2m | -CN¥261m |
Compensation vs Market: Jun's total compensation ($USD677.06K) is above average for companies of similar size in the Hong Kong market ($USD233.03K).
Compensation vs Earnings: Jun's compensation has increased whilst the company is unprofitable.
CEO
Jun Liu (55 yo)
5.1yrs
Tenure
CN¥4,906,000
Compensation
Dr. Jun Liu serves as Chief Executive Officer at TOT BIOPHARM International Company Limited since October 15, 2020 and serves as its Executive Director since October 26, 2018. Dr. Liu serves as Chief Scien...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Chief Scientific Officer & Executive Director | 5.1yrs | CN¥4.91m | no data | |
| Senior Finance Director | 2.2yrs | no data | no data | |
| Joint Company Secretary | 5yrs | no data | no data | |
| Joint Company Secretary | 2.2yrs | no data | no data |
3.6yrs
Average Tenure
42yo
Average Age
Experienced Management: 1875's management team is considered experienced (3.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Chief Scientific Officer & Executive Director | 5.5yrs | CN¥4.91m | no data | |
| Chairman of the Board | 8.3yrs | no data | no data | |
| Independent Non-Executive Director | 5.1yrs | CN¥253.00k | no data | |
| Non-Executive Vice Chairman of the Board | 8.3yrs | CN¥2.70m | 0.71% CN¥ 8.3m | |
| Independent Non-Executive Director | 5.1yrs | CN¥253.00k | no data | |
| Non-Executive Director | less than a year | no data | no data | |
| Independent Non-Executive Director | 2.1yrs | CN¥203.00k | no data |
5.1yrs
Average Tenure
55yo
Average Age
Experienced Board: 1875's board of directors are considered experienced (5.1 years average tenure).